Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Researchers from Philadelphia-based Temple University Health System have developed an EHR-integrated tool to detect pulmonary arterial hypertension, a form of heart failure, according to a study ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Hypertension is the most common chronic condition among adults aged 85 years and older, with the prevalence higher among ...

Sickle cell disease affects thousands of Indian children, yet its most dangerous complications often go unnoticed. Experts ...